newsfilter
← Latest News
GlobeNewswire·

Bionano Announces Bionano Symposium 2026: Global Experts Showcase Advances and Innovation in Optical Genome Mapping

  • Bionano Genomics, Inc. announced Bionano Symposium 2026, a virtual global event for the optical genome mapping (OGM) community scheduled for February 23-26, 2026.
  • The four-day program features presentations from over 30 researchers across North America, Europe, and Asia covering hematologic malignancies, solid tumors, bioprocessing, constitutional genetic disorders, and gene cell therapy.
  • Sessions begin daily at 7:00 AM PST, including technology introductions, remarks from Chief Medical Officer Dr. Alka Chaubey, external speaker presentations, panel discussions, Q&A, and access to a virtual poster hall.
  • Monday, February 23 focuses on advancements in hematologic malignancies with experts discussing OGM workflow performance, precision, sensitivity, and pathogenic structural variant identification.
  • Tuesday, February 24 covers new frontiers in oncology research and bioprocessing, highlighting OGM's role in detecting driver structural variants in solid tumors and its use as a quality control tool for cell gene therapy.
  • Wednesday, February 25 addresses OGM applications in constitutional genetic disorder research, including rare developmental disorders, reproductive conditions, and recurrent pregnancy loss.
  • Thursday, February 26 provides an overview of Bionano's product landscape, including Ionic, Saphyr, Stratys systems, and VIA software, featuring live demos and customer discussions on FFPE DNA isolation and high-throughput applications.
  • Registration for the symposium is free for all attendees, with opportunities to submit posters via the official virtual platform.
  • Bionano Genomics provides genome analysis solutions using OGM, proprietary isotachophoresis (ITP) technology, and diagnostic services through its Lineagen business unit.
  • The press release includes forward-looking statements regarding OGM utility, commercial goals, financing needs, and risks related to market conditions, competition, and regulatory factors.